News Alerts

08 Dec 2019 | 01:04 AM UTC

Fiji: Officials confirm 18 cases of measles as of December 7

Fiji News Alert

Health officials in Fiji confirm at least 18 cases of measles in Central division as of December 7; vaccination campaign ongoing

TIMEFRAME expected from 12/7/2019, 12:00 AM until 1/1/2020, 11:59 PM (Pacific/Fiji). COUNTRY/REGION Fiji

Read all related news alert(s):

Event

The Fiji Ministry of Health and Medical Services has confirmed 18 cases of measles in the Central division as of Saturday, December 7. Cases are being reported in the Serua/Namosi subdivision, Suva, and Rewa areas. A vaccination campaign is ongoing in Central division, with over 45,000 people being immunized between Thursday, December 5, and Friday, December 6. In order to prevent further spread of the disease, Fijian officials have asked for all sporting competitions to be postponed to January 2020.

Further spread of the disease is possible over the coming weeks.

Context

Measles is a highly contagious viral disease that typically affects mostly children. It is transmitted via droplets from the nose, mouth, or throat of infected persons. Symptoms of measles are usually a high fever, which begins approximately ten to 12 days after exposure to the virus and lasts four to seven days. A runny nose, a cough, red and watery eyes, and small white spots inside the cheeks can develop in the initial stage. After several days, a rash erupts, usually on the face and upper neck. Over the course of about three days, the rash spreads, eventually reaching the hands and feet. The rash lasts for five to six days and then fades. On average, the rash occurs 14 days after exposure to the virus (within a range of seven to 18 days). A vaccine is available.

Advice

Individuals in Fiji are advised to ensure their measles vaccination is up to date (including booster shots) and to contact their doctor with any questions or concerns. Anyone experiencing the above symptoms is urged to seek immediate medical attention.

 

Copyright and Disclaimer
GardaWorld is the owner or licensee of all intellectual property rights in the material presented on this website. All such rights are reserved. The use of this website and its material is subject to the Terms of Use and accordingly you must not use any content from this website for commercial or other analogous purposes without our consent, including but not limited to any deep-linking or framing in order to copy, distribute, display or monitor any portion of the website. If you have any questions or are interested in distributing any content from this website, Contact us for more details.

Related news